Search for a research project
80 Result(s)
Funded by an IRDiRC member = 
Research projects
AUSTRIA
TIROL
INNSBRUCK
Mechanism of erythropoietin-dependent increase in frataxin
Universität Innsbruck
Institut für Biochemie
BELGIUM
ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
European Friedreich's Ataxia Consortium for Translational Studies
Erasme Hospital - ULB
Clinique de Génétique Médicale
CANADA
Québec
QUÉBEC
Development of a treatment for Friedreich ataxia based on the administration of a TALE driving the expression of frataxin.
CHUQ - (CHUL) Centre hospitalier de l'Université Laval
Laboratoire de Génétique Humaine
FRANCE
ILE-DE-FRANCE
PARIS
FiFA2: Fighting Friedreich's Ataxia: combining multi-organisms screening and chemical optimization to generate new therapeutic molecules for FA
Université Denis Diderot - Paris 7
Equipe "Mitochondries, Métaux et Stress Oxydant"
GERMANY
Nordrhein-Westfalen
AACHEN
NICOFA : Nicotinamide for the treatment of Friedreich ataxia -DE-
Universitätsklinikum Aachen
Klinik für Neurologie
GERMANY
Nordrhein-Westfalen
BONN
NICOFA : Nicotinamide for the treatment of Friedreich ataxia -DE-
Projektträger im Deutschen Zentrum für Luft- und Raumfahrt
ERA-Net for research programs on rare diseases - Germany
ITALY
CAMPANIA
NAPOLI
Telomere shortening in Friedreich's Ataxia patients
Azienda Ospedaliera Universitaria "Federico II"
Laboratorio di Genetica Medica
ITALY
FRIULI VENEZIA GIULIA
TRIESTE
RNA therapeutics for Friedreich's Ataxia
Scuola Internazionale Superiore di Studi Avanzati
Laboratorio di Neurobiologia Molecolare
ITALY
LAZIO
ROMA
Molecular determinants of neurodegenerative diseases
IRCCS Ospedale Pediatrico Bambino Gesù
Unità di Malattie Neuromuscolari e Neurodegenerative - Laboratorio di Medicina Molecolare
SPAIN
Comunidad Valenciana
VALENCIA
BioMeder - Degenerative neuromuscular diseases: Charcot-Marie-Tooth neuropathy type 4A and Friedreich ataxia
Instituto de Biomedicina de Valencia (CSIC)
Unidad de Genética y Medicina Molecular
SPAIN
Comunidad Valenciana
VALENCIA
Phosphodiesterase inhibitors as a treatment for Friedreich's ataxia
Universitat de València. Facultat de Medicina i Odontologia
Grupo de Investigación en Fisiopatología del Estrés Oxidativo
SPAIN
Madrid
CANTOBLANCO
Neurodegeneration in Friedreich's ataxia: molecular basis and therapy approaches
CBMSO - Centro de Biología Molecular Severo Ochoa
Reparación Neuronal y Terapia Molecular en Neurodegeneración. Ataxias Espinocerebelosas
SPAIN
Madrid
CANTOBLANCO
Neuron-validated Approaches for Developing Friedreich's Ataxia Therapeutics
Universidad Autónoma de Madrid. Facultad de Ciencias
Departamento de Biología Molecular
UNITED KINGDOM
Avon
BRISTOL
Developing stem cell therapies for Friedreich's Ataxia
University of Bristol
Department of Neurology
UNITED KINGDOM
Greater London
LONDON
Restoration of Frataxin gene expression in Friedreich's ataxia -identification and characterisation of novel epigenetic therapies
Hammersmith Hospital
Gene Control Mechanisms and Disease Research Group
UNITED KINGDOM
Greater London
LONDON
Longitudinal Analysis of the Natural History of Friedreich's Ataxia
UCL Institute of Neurology, University College London,
Clinical Neurosciences
UNITED KINGDOM
Greater London
UXBRIDGE
Development of an improved GAA repeat expansion mutation-based mouse model of Friedreich ataxia for therapeutic testing
Brunel University
School of Health Sciences and Social Care
UNITED KINGDOM
Oxfordshire
OXFORD
Neuron-validated Approaches for Developing Friedreich's Ataxia Therapeutics
Le Gros Clark Building - University of Oxford
Neuroscience
UNITED KINGDOM
Cambridgeshire
CAMBRIDGE
Active BRIDGE Studies - Specialist Pathology: Evaluating Exomes in Diagnostics (SPEED)
Wellcome Trust/MRC Building
Cambridge Institute for Medical Research
FRANCE
ALSACE
ILLKIRCH-GRAFFENSTADEN
PREPARE : Preparing for therapies in autosomal recessive ataxias - FR
Institut de génétique et de biologie moléculaire et cellulaire - IGBMC
Département Médecine translationnelle et neurogénétique
FRANCE
ILE-DE-FRANCE
PARIS
SPATAX-QUEST: Identification of new causative genes in spinocerebellar degenerations by combination of whole genome scan, next-generation sequencing and biological validation in vitro and in vivo
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
Equipe "Bases moléculaires, physiopathologie et traitement des maladies neurodégénératives"
FRANCE
ILE-DE-FRANCE
PARIS
PREPARE : Preparing for therapies in autosomal recessive ataxias - FR
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
Equipe "Bases moléculaires, physiopathologie et traitement des maladies neurodégénératives"
GERMANY
Baden-Württemberg
TÜBINGEN
PREPARE : Preparing for therapies in autosomal recessive ataxias (coordination) - DE
Hertie-Institut für klinische Hirnforschung (HIH)
Abteilung Neurologie mit Schwerpunkt neurodegenerative Erkrankungen
GERMANY
Nordrhein-Westfalen
BONN
PREPARE : Preparing for therapies in autosomal recessive ataxias (coordination) - DE
Projektträger im Deutschen Zentrum für Luft- und Raumfahrt
ERA-Net for research programs on rare diseases - Germany
ITALY
LAZIO
ROMA
SPATAX: European network for hereditary spinocerebellar degenerative disorders
Fondazione EBRI
Istituto di Neurobiologia e Medicina Molecolare
PORTUGAL
NORTE
PORTO
SPATAX: Clinical and Genetic Analysis of Cerebellar Ataxias and Spastic Paraplegias
Instituto de Biologia Molecular e Celular
Centro de Genética Preditiva e Preventiva
PORTUGAL
NORTE
PORTO
Clinical implications of genetic factors causing neurodegenerative diseases characterized by movement or cognitive dysfunction.
Instituto de Biologia Molecular e Celular
Unidade de Investigação Genética e Epidemiológica em Doenças Neurológicas
PORTUGAL
NORTE
PORTO
SPATAX: Clinical and Genetic Analysis of Cerebellar Ataxias and Spastic Paraplegias
Instituto de Biologia Molecular e Celular
Unidade de Investigação Genética e Epidemiológica em Doenças Neurológicas
PORTUGAL
NORTE
SANTA MARIA DA FEIRA
SPATAX: Clinical and Genetic Analysis of Cerebellar Ataxias and Spastic Paraplegias
Hospital São Sebastião
Serviço de Neurologia
UNITED KINGDOM
Berkshire
READING
Therapeutic potential of modulators of cannabinoid receptors in cerebellar ataxias
University of Reading
School of Pharmacy
UNITED KINGDOM
Greater London
LONDON
Endogenous Cerebellar Human Stem Cells and their Potential Neuroregenerative Role in Inherited Ataxias
Barts and The London School of Medicine and Dentistry
Centre for Neuroscience and Trauma
UNITED KINGDOM
Greater London
LONDON
Coenzyme Q10 a potential therapeutic target for ataxia: Evaluation of therapeutic strategies
Great Ormond Street Hospital for Children, NHS Foundation Trust
Department of Chemical Pathology
UNITED KINGDOM
Greater London
LONDON
Coenzyme Q10 a potential therapeutic target for ataxia: Evaluation of therapeutic strategies
National Hospital for Neurology and Neurosurgery
Department of Molecular Neuroscience
UNITED KINGDOM
Greater London
LONDON
Coenzyme Q10 a potential therapeutic target for ataxia: Evaluation of therapeutic strategies
UCL Institute of Child Health, University College London
Metabolic Unit
UNITED KINGDOM
Lothian
EDINBURGH
Developing non-invasive therapeutic technology to improve motor coordination in cerebellar ataxias
PMARC - The University of Edinburgh
Perception-Movement-Action Research Consortium
UNITED KINGDOM
Lothian
EDINBURGH
Developing non-invasive therapeutic technology to improve motor coordination in cerebellar ataxias
School of Informatics, The University of Edinburgh
Human Communication Research Centre
UNITED KINGDOM
Lothian
EDINBURGH
Genetic disorders of human brain development
Western General Hospital
MRC Human Genetics Unit
UNITED KINGDOM
Oxfordshire
OXFORD
Development of high throughput genetic testing for cerebellar ataxias
Henry Wellcome Building for Molecular Physiology
BRC Genetics and Pathology Theme
UNITED KINGDOM
Oxfordshire
OXFORD
Development of high throughput genetic testing for cerebellar ataxias
Le Gros Clark Building - University of Oxford
MRC Functional Genetics Unit
UNITED KINGDOM
Oxfordshire
OXFORD
Development of high throughput genetic testing for cerebellar ataxias
The Churchill Hospital
Molecular Genetics Laboratory
UNITED KINGDOM
Oxfordshire
OXFORD
Development of high throughput genetic testing for cerebellar ataxias
The Churchill Hospital
Department of Clinical Genetics
BELGIUM
ANTWERPEN
ANTWERPEN
NEUROMICS: Integrated European Project on Omics Research of Rare Neuromuscular and Neurodegenerative Diseases - BE
University of Antwerp - UA
VIB Department of Molecular Genetics
FRANCE
ILE-DE-FRANCE
PARIS
Neuromics: Integrated European -omics research project for diagnosis and therapy in rare neuromuscular and neurodegenerative diseases - FR
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
Equipe "Bases moléculaires, physiopathologie et traitement des maladies neurodégénératives"
GERMANY
Baden-Württemberg
TÜBINGEN
NEUROMICS: Integrated European Project on Omics Research of Rare Neuromuscular and Neurodegenerative Diseases - UK
Institut für Medizinische Genetik und angewandte Genomik Tübingen
Institut für Medizinische Genetik und angewandte Genomik
GERMANY
Baden-Württemberg
TÜBINGEN
NEUROMICS: Integrated European Project on Omics Research of Rare Neuromuscular and Neurodegenerative Diseases -DE-
Institut für Medizinische Genetik und angewandte Genomik Tübingen
Institut für Medizinische Genetik und angewandte Genomik
GERMANY
Nordrhein-Westfalen
BONN
NEUROMICS: Integrated European Project on Omics Research of Rare Neuromuscular and Neurodegenerative Diseases -DE-
Universitätsklinikum Bonn
Klinik und Poliklinik für Neurologie
GERMANY
Nordrhein-Westfalen
KÖLN
NEUROMICS: Integrated European Project on Omics Research of Rare Neuromuscular and Neurodegenerative Diseases -DE-
Institut für Humangenetik am Universitätsklinikum Köln
Institut für Humangenetik
ITALY
LOMBARDIA
MILANO
NEUROMICS: Integrated European Project on Omics Research of Rare Neuromuscular and Neurodegenerative Diseases - IT
Università degli Studi di Milano - Scienze Farmacologiche e Biomolecolari
Laboratorio di Biologia delle Cellule Staminali
NETHERLANDS
Gelderland
NIJMEGEN
NETHERLANDS
Zuid-Holland
LEIDEN
NEUROMICS: Integrated European -omics research project for diagnosis and therapy in rare neuromuscular and neurodegenerative diseases - NL
LUMC - Leids Universitair Medisch Centrum
Afdeling Humane Genetica
UNITED STATES
Arizona
PHOENIX
The etiology of inherited neurological diseases
Phoenix Children's Hospital
Barrow Neurological Institute
CANADA
Alberta
CALGARY
Muscle rehabilitation of cerebral palsy patients recieving botulinum toxin type-A (Botox) treatments
University of Calgary
Faculty of Kinesiology
ITALY
PIEMONTE
TORINO
Functional characterization of missense mutations in SCA28 patients, development of a mouse model of the disease, and screening of candidate genes for cerebellar ataxia
A.O. Città della Salute e della Scienza di Torino - Ospedale Molinette
Genetica Medica
UNITED KINGDOM
Oxfordshire
OXFORD
Clinical and Genetic Analysis of Ataxias and Related Disorders of Cerebellar Function
The Churchill Hospital
Department of Clinical Genetics
GERMANY
Bayern
MÜNCHEN
RHAPSODY - Research to Assess Policies and Strategies for Dementia in the Young
Klinikum rechts der Isar der Technischen Universität München
Klinik und Poliklinik für Psychiatrie und Psychotherapie
Multicentric Research projects
- Erasme Hospital - ULB
- Clinique de Génétique Médicale
- Universitätsklinikum Aachen
- GeNeMove - Netzwerksekretariat
- Universitätsklinikum Aachen
- Klinik für Neurologie
- Instituto de Biomedicina de Valencia (CSIC)
- Unidad de Genética y Medicina Molecular
- HSK, Dr. Horst Schmidt Kliniken GmbH
- Zentrum für Seltene Erkrankungen (ZSE) Wiesbaden
- CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
- Equipe "Bases moléculaires, physiopathologie et traitement des maladies neurodégénératives"
- IURC - Institut Universitaire de Recherche Clinique
- Laboratoire de génétique moléculaire
- Hertie-Institut für klinische Hirnforschung (HIH)
- Abteilung Neurologie mit Schwerpunkt neurodegenerative Erkrankungen
- Zentrum für Neuropathologie und Prionforschung (ZNP)
- Zentrum für Neuropathologie und Prionforschung der LMU München
- Fondazione EBRI
- Istituto di Neurobiologia e Medicina Molecolare
- Hospital Universitari de Bellvitge
- Unidad de Neuropatología
- University of British Columbia
- Maternal Infant Child and Youth Research Network
- Institut für Medizinische Genetik und angewandte Genomik Tübingen
- Institut für Medizinische Genetik und angewandte Genomik
- IRCCS Ospedale Pediatrico Bambino Gesù - SEDE GIANICOLO
- Servizio Clinico di Consulenza Genetica
- Institut für Medizinische Genetik und angewandte Genomik Tübingen
- Institut für Medizinische Genetik und angewandte Genomik
- Universitätsklinikum Bonn
- Kompetenznetz Degenerative Demenzen - Geschäftsstelle
- Camden Mews Day Hospital
- North Thames DeNDRoN, Camden & Islington Mental Health Trust
- Wythenshawe Hospital
- Dementias & Neurodegenerative Diseases Research Network
- Moorgreen Hospital
- Memory & Assessment & Research Centre
- Julian Hospital
- The Churchill Hospital
- Fulbrook Centre
- St Martin's Hospital
- Research Institute for the Care of the Elderly (RICE)
- Newcastle General Hospital
- Wolfson Research Centre
- Alzheimer Europe Office
- Max-Planck-Institut für experimentelle Medizin
- Abteilung Molekulare Neurobiologie
BELGIUM
ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
EFACTS - EUROFA: European Friedreich's ataxia consortium for translational studies
GERMANY
Nordrhein-Westfalen
AACHEN
GeNeMove: German Network of Hereditary Movement Disorders
GERMANY
Nordrhein-Westfalen
AACHEN
NICOFA : Nicotinamide for the treatment of Friedreich ataxia
SPAIN
Comunidad Valenciana
VALENCIA
BioMeder - Genes, proteins and signaling pathways in rare diseases
GERMANY
Hessen
WIESBADEN
InNerMeD-I-Network: Inherited NeuRoMetabolic Diseases Information Network
FRANCE
ILE-DE-FRANCE
PARIS
SPATAX: European network for hereditary spinocerebellar degenerative disorders
FRANCE
LANGUEDOC-ROUSSILLON
MONTPELLIER
Euro-SCAR: Nosology and molecular diagnosis of the degenerative recessive ataxias
GERMANY
Baden-Württemberg
TÜBINGEN
PREPARE : Preparing for therapies in autosomal recessive ataxias
GERMANY
Bayern
MÜNCHEN
BNE: BrainNet Europe II: European brain tissue bank
ITALY
LAZIO
ROMA
ITASPA: clinical and genetic analysis of spastic paraplegias
SPAIN
Cataluña
L'HOSPITALET DE LLOBREGAT
CIEN: Spanish Network for Cooperative Research in Neurological diseases
CANADA
Colombie-Britannique
VANCOUVER
Maternal Infant Child and Youth Research Network (MICYRN)
GERMANY
Baden-Württemberg
TÜBINGEN
Neuromics: Integrated European -omics research project for diagnosis and therapy in rare neuromuscular and neurodegenerative diseases
ITALY
LAZIO
ROMA
UnRareNet: a muticenter collaborative research network for the identification and study of rare undiagnosed patients (completed)
GERMANY
Baden-Württemberg
TÜBINGEN
Ataxia Study Group (ASG)
GERMANY
Nordrhein-Westfalen
BONN
Competence Network Degenerative Dementias
UNITED KINGDOM
Greater London
LONDON
DENDRON - north Thames region: Dementias & Neurodegenerative Diseases Research Network
UNITED KINGDOM
Greater Manchester
MANCHESTER
DENDRON - north west region: Dementias & Neurodegenerative Diseases Research Network
UNITED KINGDOM
Hampshire
SOUTHAMPTON
DENDRON - south coast region: Dementias & Neurodegenerative Diseases Research Network
UNITED KINGDOM
Norfolk
NORWICH
DENDRON - east Anglia region: Dementias & Neurodegenerative Diseases Research Network
UNITED KINGDOM
Oxfordshire
OXFORD
DENDRON - Thames valley region: Dementias & Neurodegenerative Diseases Research Network
UNITED KINGDOM
Somerset
BATH
DENDRON - south west region: Dementias & Neurodegenerative Diseases Research Network
UNITED KINGDOM
Tyne & Wear
NEWCASTLE UPON TYNE
DENDRON - north east region: Dementias & Neurodegenerative Diseases Research Network
LUXEMBOURG
LUXEMBOURG
LUXEMBOURG
Alzheimer Europe: base de données européenne sur les formes rares de démence
GERMANY
Niedersachsen
GÖTTINGEN